Europe Spirometer Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024
The Europe Spirometer Market is expected to reach USD 349.25 million by 2024, from USD 177.79 million in 2016 growing at a CAGR of 8.9% in the forecast period 2017 to 2024.
The major factors driving the growth of this market are increasing prevalence of respiratory diseases, increased demand of homecare setting devices, and rise in the number of smokers.
The key market players for Europe Spirometer Market are listed below:
Based on technology, the Europe spirometer market is segmented into volume measurement spirometer, flow measurement spirometer and peak flow meter. In 2017, flow measurement spirometer is expected to dominate the Europe spirometer market with 68.4% market share and is expected to reach USD 244.9 million by 2024, growing at a CAGR of 9.3% in the forecast period 2017 to 2024.
Based on, the Europe spirometer market is segmented into asthma, bronchitis, emphysema, chronic obstructive lung disease, lung cancer, and others. In 2017, chronic obstructive lung disease is expected to dominate the Europe spirometer market with 42.7% market share and is expected to reach USD 154.0 million by 2024, growing with the highest CAGR of 9.4% in the forecast period 2017 to 2024.
Based on disposable components, the Europe spirometer market is segmented into filters, tubes and sensors. In 2017, filters is expected to dominate the Europe spirometer market with 75.0% market share and is expected to reach USD 265.4 million by 2024, growing with the highest CAGR of 9.1% in the forecast period 2017 to 2024.
Based on application, the Europe spirometer market is segmented into diagnostics and therapeutics. In 2017, diagnostics is expected to dominate the Europe spirometer market with 65.8% market share and is expected to reach USD 238.1 million by 2024, growing with the highest CAGR of 9.5% in the forecast period 2017 to 2024.
Based on end-user, the Europe spirometer market is segmented into hospitals, clinics and homecare. In 2017, hospitals is expected to dominate the Europe spirometer market with 51.0% market share and is expected to reach USD 183.7 million by 2024, growing at a CAGR of 9.4% in the forecast period 2017 to 2024.
Based on distribution channel, the Europe spirometer market is segmented into direct tender and over the counter. In 2017, direct tender is expected to dominate the Europe spirometer market with 65.1% market share and is expected to reach USD 232.3 million by 2024, growing at a CAGR of 9.3% in the forecast period 2017 to 2024.
Based on geography, the Europe Spirometer market is segmented into 11 geographical regions, such as,
The report covers the present scenario and the growth prospects of the Europe Spirometer market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
The major factors driving the growth of this market are increasing prevalence of respiratory diseases, increased demand of homecare setting devices, and rise in the number of smokers.
The key market players for Europe Spirometer Market are listed below:
- BD,
- Midmark Corp
- Welch allyn
- SDI Diagnostics,
- Geratherm Respiratory GMBH,
- Type
- Application
- End User
- Geography
Based on technology, the Europe spirometer market is segmented into volume measurement spirometer, flow measurement spirometer and peak flow meter. In 2017, flow measurement spirometer is expected to dominate the Europe spirometer market with 68.4% market share and is expected to reach USD 244.9 million by 2024, growing at a CAGR of 9.3% in the forecast period 2017 to 2024.
Based on, the Europe spirometer market is segmented into asthma, bronchitis, emphysema, chronic obstructive lung disease, lung cancer, and others. In 2017, chronic obstructive lung disease is expected to dominate the Europe spirometer market with 42.7% market share and is expected to reach USD 154.0 million by 2024, growing with the highest CAGR of 9.4% in the forecast period 2017 to 2024.
Based on disposable components, the Europe spirometer market is segmented into filters, tubes and sensors. In 2017, filters is expected to dominate the Europe spirometer market with 75.0% market share and is expected to reach USD 265.4 million by 2024, growing with the highest CAGR of 9.1% in the forecast period 2017 to 2024.
Based on application, the Europe spirometer market is segmented into diagnostics and therapeutics. In 2017, diagnostics is expected to dominate the Europe spirometer market with 65.8% market share and is expected to reach USD 238.1 million by 2024, growing with the highest CAGR of 9.5% in the forecast period 2017 to 2024.
Based on end-user, the Europe spirometer market is segmented into hospitals, clinics and homecare. In 2017, hospitals is expected to dominate the Europe spirometer market with 51.0% market share and is expected to reach USD 183.7 million by 2024, growing at a CAGR of 9.4% in the forecast period 2017 to 2024.
Based on distribution channel, the Europe spirometer market is segmented into direct tender and over the counter. In 2017, direct tender is expected to dominate the Europe spirometer market with 65.1% market share and is expected to reach USD 232.3 million by 2024, growing at a CAGR of 9.3% in the forecast period 2017 to 2024.
Based on geography, the Europe Spirometer market is segmented into 11 geographical regions, such as,
- Germany,
- France,
- United Kingdom,
- Italy,
- Spain,
- Russia,
- Turkey,
- Belgium,
- Netherlands,
- Switzerland,
- Rest of Europe
The report covers the present scenario and the growth prospects of the Europe Spirometer market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
1. INTRODUCTION
1.1. OVERVIEW OF THE EUROPE SPIROMETER MARKET
1.2. CURRENCY AND PRICING
1.3. LIMITATION
1.4. MARKETS COVERED
2 MARKET SEGMENTATION
2.1. KEY TAKEAWAYS
2.2. ARRIVING AT THE EUROPE SPIROMETER MARKET SIZE
2.2.1 VENDOR POSITIONING GRID
2.2.2 TECHNOLOGY LIFE LINE CURVE
2.2.3 MARKET TIME LINE
2.2.4 MARKET GUIDE
2.2.5 COMPANY POSITIONING GRID
2.2.6 COMAPANY MARKET SHARE ANALYSIS
2.2.7 MULTIVARIATE MODELLING
2.2.8 STANDARDS OF MEASUREMENT
2.2.9 TOP TO BOTTOM ANALYSIS
2.2.10 VENDOR SHARE ANALYSIS
2.2.11 DATA POINTS FROM KEY PRIMARY INTERVIEWS
2.2.12 DATA POINTS FROM KEY SECONDARY DATABASES
2.3. EUROPE SPIROMETER MARKET: RESEARCH SNAPSHOT
2.4. ASSUMPTIONS
3 MARKET OVERVIEW
3.1. DRIVERS
3.1.1. RISING INCIDENCE OF RESPIRATORY DISEASES
3.1.2. TECHNOLOGICAL ADVANCEMENTS IN RESPIRATORY DEVICES
3.1.3. INCREASED DEMAND OF HOMECARE SETTING DEVICES
3.2. RESTRAINTS
3.2.1. WEAK REIMBURSEMENT POLICIES
3.3. OPPORTUNITIES
3.3.1. TECHNOLOGY DRIVING THE MARKET PROVIDES OPPURTUNITY TO UPCOMING PLAYERS
3.3.2. GOVERNMENT INITIATIVES TO CREATE AWARNESS REGARDING RESPIRATORY DISEASES AND ITS TREATMENT
3.4. CHALLENGES
3.4.1. LACK OF TRAINED PROFESSIONALS FOR SUPERVISING HIGH QUALITY SPIROMETERS
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
5.1. EPIDEMIOLOGY STATISTICS OF CHRONIC OBSTRUCTIVE
LUNG DISEASE
5.2. POPULATION DATA STATISTICS OF DIFFERENT TYPES OF RESPIRATORY DISEASES
5.3. VENDOR POSITIONING GRID AND INVESTMENT OPPURTUNITIES
5.4. TECHNOLOLGICAL ADVANCEMENTS
5.5. REIMBURSEMENT RATES
5.6. INSIGHTS ON TECHNOLOGICAL DEVELOPMENTS IN THE EUROPE SPIROMETER MARKET
5.7. MARKET REGULATORY SCENARIO
5.8. INTERVIEW KEY INSIGHTS
6 EUROPE SPIROMETER MARKET, BY PRODUCT TYPE
6.1. OVERVIEW
6.2. TABLE-TOP SPIROMETER
6.3. HAND-HELD SPIROMETER
6.4. DESKTOP SPIROMETER
7 EUROPE SPIROMETER MARKET, BY TECHNOLOGY
7.1. OVERVIEW
7.2. VOLUME MEASUREMENT SPIROMETER
7.2.1 WET SPIROMETERS
7.2.2. DRY SPIROMETERS
7.3. FLOW MEASUREMENT SPIROMETER
7.3.1 PNEUMO-TACHOGRAPH SYSTEMS
7.3.2. MASS FLOW METERS
7.4. PEAK FLOW METER
7.5. OTHERS
8 EUROPE SPIROMETER MARKET, BY DISEASE
8.1. OVERVIEW
8.2. ASTHMA
8.3. BRONCHITIS
8.4. EMPHYSEMA
8.5. CHRONIC OBSTRUCTIVE LUNG DISEASE
8.6. LUNG CANCER
8.7. OTHERS
9 EUROPE SPIROMETER MARKET, BY DISPOSABLE COMPONENTS
9.1. OVERVIEW
9.2. FILTERS
9.3. SENSORS
9.4. TUBES
10 EUROPE SPIROMETER MARKET, BY APPLICATION
10.1. OVERVIEW
10.2. DIAGNOSTICS
10.3. THERAPEUTIC
11 EUROPE SPIROMETER MARKET, BY END-USER
11.1. OVERVIEW
11.2. HOSPITALS
11.3. CLINICS
11.4. HOMECARE
12 EUROPE SPIROMETER MARKET, BY DISTRIBUTION CHANNEL
12.1. OVERVIEW
12.2. OVER THE COUNTER
12.3. DIRECT TENDER
13 EUROPE SPIROMETER MARKET: COMPETITIVE LANDSCAPE
13.1. EUROPE SPIROMETER MARKET: COMPANY SHARE ANALYSIS
13.2. MERGERS & ACQUISITIONS
13.3. NEW PRODUCT DEVELOPMENT & APPROVALS
13.4. EXPANSIONS
13.5. REGULATORY CHANGES
13.6. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
14 EUROPE SPIROMETER MARKET, COMPANY PROFILES
14.1 WELCH ALLYN
14.1.1 COMPANY OVERVIEW
14.1.2. FINANCIAL ANALYSIS
14.1.3. PRODUCT MATRIX
14.1.4 RECENT DEVELOPMENTS
14.1.5. DATABRIDGE ANALYSIS
14.2 MIDMARK CORP.
14.2.1. COMPANY OVERVIEW
14.2.2 FINANCIAL ANALYSIS
14.2.3 PRODUCT MATRIX
14.2.4. RECENT DEVELOPMENTS
14.2.5. DATABRIDGE ANALYSIS
14.3 FUTUREMED
14.3.1. COMPANY OVERVIEW
14.3.2. FINANCIAL ANALYSIS
14.3.3. PRODUCT MATRIX
14.3.4. RECENT DEVELOPMENTS
14.3.5. DATABRIDGE ANALYSIS
14.4 COSMED
14.4.1. COMPANY OVERVIEW
14.4.2. FINANCIAL ANALYSIS
14.4.3. PRODUCT MATRIX
14.4.4. RECENT DEVELOPMENTS
14.4.5. DATABRIDGE ANALYSIS
14.5 MGC DIAGNOSTICS CORPORATION
14.5.1. COMPANY OVERVIEW
14.5.2. FINANCIAL ANALYSIS
14.5.3. PRODUCT MATRIX
14.5.4. RECENT DEVELOPMENTS
14.5.5. DATABRIDGE ANALYSIS
14.6 NIHON KOHDEN CORPORATION
14.6.1. COMPANY OVERVIEW
14.6.2. FINANCIAL ANALYSIS
14.6.3. PRODUCT MATRIX
14.6.4. RECENT DEVELOPMENTS
14.6.5. DATABRIDGE ANALYSIS
14.7 CHEST M.I., INC
14.7.1. COMPANY OVERVIEW
14.7.2. FINANCIAL ANALYSIS
14.7.3. PRODUCT MATRIX
14.7.4. RECENT DEVELOPMENTS
14.7.5. DATABRIDGE ANALYSIS
14.8 MEDICAL INTERNATIONAL RESEARCH
14.8.1. COMPANY OVERVIEW
14.8.2. FINANCIAL ANALYSIS
14.8.3. PRODUCT MATRIX
14.8.4. RECENT DEVELOPMENTS
14.8.5. DATABRIDGE ANALYSIS
14.9 VITALOGRAPH
14.9.1. COMPANY OVERVIEW
14.9.2. FINANCIAL ANALYSIS
14.9.3. PRODUCT MATRIX
14.9.4. RECENT DEVELOPMENTS
14.9.5. DATABRIDGE ANALYSIS
14.10 NDD MEDIZINTECHNIK AG
14.10.1. COMPANY OVERVIEW
14.10.2. FINANCIAL ANALYSIS
14.10.3. PRODUCT MATRIX
14.10.4. RECENT DEVELOPMENTS
14.10.5. DATABRIDGE ANALYSIS
14.11 SCHILLER
14.11.1. COMPANY OVERVIEW
14.11.2. FINANCIAL ANALYSIS
14.11.3. PRODUCT MATRIX
14.11.4. RECENT DEVELOPMENTS
14.11.5. DATABRIDGE ANALYSIS
14.12 JONES MEDICAL INSTRUMENT COMPANY
14.12.1. COMPANY OVERVIEW
14.12.2. FINANCIAL ANALYSIS
14.12.3. PRODUCT MATRIX
14.12.4. RECENT DEVELOPMENTS
14.12.5. DATABRIDGE ANALYSIS
14.13 SDI DIAGNOSTICS
14.13.1. COMPANY OVERVIEW
14.13.2. FINANCIAL ANALYSIS
14.13.3. PRODUCT MATRIX
14.13.4. RECENT DEVELOPMENTS
14.13.5. DATABRIDGE ANALYSIS
14.14 GERATHERN RESPIRATORY GMBH
14.14.1. COMPANY OVERVIEW
14.14.2. FINANCIAL ANALYSIS
14.14.3. PRODUCT MATRIX
14.14.4. RECENT DEVELOPMENTS
14.14.5. DATABRIDGE ANALYSIS
14.15 THOR
14.15.1. COMPANY OVERVIEW
14.15.2. FINANCIAL ANALYSIS
14.15.3. PRODUCT MATRIX
14.15.4. RECENT DEVELOPMENTS
14.15.5. DATABRIDGE ANALYSIS
14.16 FUKUDA SANGYO INC.
14.16.1. COMPANY OVERVIEW
14.16.2. FINANCIAL ANALYSIS
14.16.3. PRODUCT MATRIX
14.16.4. RECENT DEVELOPMENTS
14.16.5. DATABRIDGE ANALYSIS
14.17 CONTEC MEDICAL SYSTEMS CO., LTD.
14.17.1. COMPANY OVERVIEW
14.17.2. FINANCIAL ANALYSIS
14.17.3. PRODUCT MATRIX
14.17.4. RECENT DEVELOPMENTS
14.17.5. DATABRIDGE ANALYSIS
14.18 KONINKLIJKE PHILIPS N.V.
14.18.1. COMPANY OVERVIEW
14.18.2. FINANCIAL ANALYSIS
14.18.3. PRODUCT MATRIX
14.18.4. RECENT DEVELOPMENTS
14.18.5. DATABRIDGE ANALYSIS
14.19 BD
14.19.1. COMPANY OVERVIEW
14.19.2. FINANCIAL ANALYSIS
14.19.3. PRODUCT MATRIX
14.19.4. RECENT DEVELOPMENTS
14.19.5. DATABRIDGE ANALYSIS
14.20 CARDIOTECH
14.20.1. COMPANY OVERVIEW
14.20.2. FINANCIAL ANALYSIS
14.20.3. PRODUCT MATRIX
14.20.4. RECENT DEVELOPMENTS
14.20.5. DATABRIDGE ANALYSIS
15 APPENDIX
16 ABOUT DATA BRIDGE MARKET RESEARCH
1.1. OVERVIEW OF THE EUROPE SPIROMETER MARKET
1.2. CURRENCY AND PRICING
1.3. LIMITATION
1.4. MARKETS COVERED
2 MARKET SEGMENTATION
2.1. KEY TAKEAWAYS
2.2. ARRIVING AT THE EUROPE SPIROMETER MARKET SIZE
2.2.1 VENDOR POSITIONING GRID
2.2.2 TECHNOLOGY LIFE LINE CURVE
2.2.3 MARKET TIME LINE
2.2.4 MARKET GUIDE
2.2.5 COMPANY POSITIONING GRID
2.2.6 COMAPANY MARKET SHARE ANALYSIS
2.2.7 MULTIVARIATE MODELLING
2.2.8 STANDARDS OF MEASUREMENT
2.2.9 TOP TO BOTTOM ANALYSIS
2.2.10 VENDOR SHARE ANALYSIS
2.2.11 DATA POINTS FROM KEY PRIMARY INTERVIEWS
2.2.12 DATA POINTS FROM KEY SECONDARY DATABASES
2.3. EUROPE SPIROMETER MARKET: RESEARCH SNAPSHOT
2.4. ASSUMPTIONS
3 MARKET OVERVIEW
3.1. DRIVERS
3.1.1. RISING INCIDENCE OF RESPIRATORY DISEASES
3.1.2. TECHNOLOGICAL ADVANCEMENTS IN RESPIRATORY DEVICES
3.1.3. INCREASED DEMAND OF HOMECARE SETTING DEVICES
3.2. RESTRAINTS
3.2.1. WEAK REIMBURSEMENT POLICIES
3.3. OPPORTUNITIES
3.3.1. TECHNOLOGY DRIVING THE MARKET PROVIDES OPPURTUNITY TO UPCOMING PLAYERS
3.3.2. GOVERNMENT INITIATIVES TO CREATE AWARNESS REGARDING RESPIRATORY DISEASES AND ITS TREATMENT
3.4. CHALLENGES
3.4.1. LACK OF TRAINED PROFESSIONALS FOR SUPERVISING HIGH QUALITY SPIROMETERS
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
5.1. EPIDEMIOLOGY STATISTICS OF CHRONIC OBSTRUCTIVE
LUNG DISEASE
5.2. POPULATION DATA STATISTICS OF DIFFERENT TYPES OF RESPIRATORY DISEASES
5.3. VENDOR POSITIONING GRID AND INVESTMENT OPPURTUNITIES
5.4. TECHNOLOLGICAL ADVANCEMENTS
5.5. REIMBURSEMENT RATES
5.6. INSIGHTS ON TECHNOLOGICAL DEVELOPMENTS IN THE EUROPE SPIROMETER MARKET
5.7. MARKET REGULATORY SCENARIO
5.8. INTERVIEW KEY INSIGHTS
6 EUROPE SPIROMETER MARKET, BY PRODUCT TYPE
6.1. OVERVIEW
6.2. TABLE-TOP SPIROMETER
6.3. HAND-HELD SPIROMETER
6.4. DESKTOP SPIROMETER
7 EUROPE SPIROMETER MARKET, BY TECHNOLOGY
7.1. OVERVIEW
7.2. VOLUME MEASUREMENT SPIROMETER
7.2.1 WET SPIROMETERS
7.2.2. DRY SPIROMETERS
7.3. FLOW MEASUREMENT SPIROMETER
7.3.1 PNEUMO-TACHOGRAPH SYSTEMS
7.3.2. MASS FLOW METERS
7.4. PEAK FLOW METER
7.5. OTHERS
8 EUROPE SPIROMETER MARKET, BY DISEASE
8.1. OVERVIEW
8.2. ASTHMA
8.3. BRONCHITIS
8.4. EMPHYSEMA
8.5. CHRONIC OBSTRUCTIVE LUNG DISEASE
8.6. LUNG CANCER
8.7. OTHERS
9 EUROPE SPIROMETER MARKET, BY DISPOSABLE COMPONENTS
9.1. OVERVIEW
9.2. FILTERS
9.3. SENSORS
9.4. TUBES
10 EUROPE SPIROMETER MARKET, BY APPLICATION
10.1. OVERVIEW
10.2. DIAGNOSTICS
10.3. THERAPEUTIC
11 EUROPE SPIROMETER MARKET, BY END-USER
11.1. OVERVIEW
11.2. HOSPITALS
11.3. CLINICS
11.4. HOMECARE
12 EUROPE SPIROMETER MARKET, BY DISTRIBUTION CHANNEL
12.1. OVERVIEW
12.2. OVER THE COUNTER
12.3. DIRECT TENDER
13 EUROPE SPIROMETER MARKET: COMPETITIVE LANDSCAPE
13.1. EUROPE SPIROMETER MARKET: COMPANY SHARE ANALYSIS
13.2. MERGERS & ACQUISITIONS
13.3. NEW PRODUCT DEVELOPMENT & APPROVALS
13.4. EXPANSIONS
13.5. REGULATORY CHANGES
13.6. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
14 EUROPE SPIROMETER MARKET, COMPANY PROFILES
14.1 WELCH ALLYN
14.1.1 COMPANY OVERVIEW
14.1.2. FINANCIAL ANALYSIS
14.1.3. PRODUCT MATRIX
14.1.4 RECENT DEVELOPMENTS
14.1.5. DATABRIDGE ANALYSIS
14.2 MIDMARK CORP.
14.2.1. COMPANY OVERVIEW
14.2.2 FINANCIAL ANALYSIS
14.2.3 PRODUCT MATRIX
14.2.4. RECENT DEVELOPMENTS
14.2.5. DATABRIDGE ANALYSIS
14.3 FUTUREMED
14.3.1. COMPANY OVERVIEW
14.3.2. FINANCIAL ANALYSIS
14.3.3. PRODUCT MATRIX
14.3.4. RECENT DEVELOPMENTS
14.3.5. DATABRIDGE ANALYSIS
14.4 COSMED
14.4.1. COMPANY OVERVIEW
14.4.2. FINANCIAL ANALYSIS
14.4.3. PRODUCT MATRIX
14.4.4. RECENT DEVELOPMENTS
14.4.5. DATABRIDGE ANALYSIS
14.5 MGC DIAGNOSTICS CORPORATION
14.5.1. COMPANY OVERVIEW
14.5.2. FINANCIAL ANALYSIS
14.5.3. PRODUCT MATRIX
14.5.4. RECENT DEVELOPMENTS
14.5.5. DATABRIDGE ANALYSIS
14.6 NIHON KOHDEN CORPORATION
14.6.1. COMPANY OVERVIEW
14.6.2. FINANCIAL ANALYSIS
14.6.3. PRODUCT MATRIX
14.6.4. RECENT DEVELOPMENTS
14.6.5. DATABRIDGE ANALYSIS
14.7 CHEST M.I., INC
14.7.1. COMPANY OVERVIEW
14.7.2. FINANCIAL ANALYSIS
14.7.3. PRODUCT MATRIX
14.7.4. RECENT DEVELOPMENTS
14.7.5. DATABRIDGE ANALYSIS
14.8 MEDICAL INTERNATIONAL RESEARCH
14.8.1. COMPANY OVERVIEW
14.8.2. FINANCIAL ANALYSIS
14.8.3. PRODUCT MATRIX
14.8.4. RECENT DEVELOPMENTS
14.8.5. DATABRIDGE ANALYSIS
14.9 VITALOGRAPH
14.9.1. COMPANY OVERVIEW
14.9.2. FINANCIAL ANALYSIS
14.9.3. PRODUCT MATRIX
14.9.4. RECENT DEVELOPMENTS
14.9.5. DATABRIDGE ANALYSIS
14.10 NDD MEDIZINTECHNIK AG
14.10.1. COMPANY OVERVIEW
14.10.2. FINANCIAL ANALYSIS
14.10.3. PRODUCT MATRIX
14.10.4. RECENT DEVELOPMENTS
14.10.5. DATABRIDGE ANALYSIS
14.11 SCHILLER
14.11.1. COMPANY OVERVIEW
14.11.2. FINANCIAL ANALYSIS
14.11.3. PRODUCT MATRIX
14.11.4. RECENT DEVELOPMENTS
14.11.5. DATABRIDGE ANALYSIS
14.12 JONES MEDICAL INSTRUMENT COMPANY
14.12.1. COMPANY OVERVIEW
14.12.2. FINANCIAL ANALYSIS
14.12.3. PRODUCT MATRIX
14.12.4. RECENT DEVELOPMENTS
14.12.5. DATABRIDGE ANALYSIS
14.13 SDI DIAGNOSTICS
14.13.1. COMPANY OVERVIEW
14.13.2. FINANCIAL ANALYSIS
14.13.3. PRODUCT MATRIX
14.13.4. RECENT DEVELOPMENTS
14.13.5. DATABRIDGE ANALYSIS
14.14 GERATHERN RESPIRATORY GMBH
14.14.1. COMPANY OVERVIEW
14.14.2. FINANCIAL ANALYSIS
14.14.3. PRODUCT MATRIX
14.14.4. RECENT DEVELOPMENTS
14.14.5. DATABRIDGE ANALYSIS
14.15 THOR
14.15.1. COMPANY OVERVIEW
14.15.2. FINANCIAL ANALYSIS
14.15.3. PRODUCT MATRIX
14.15.4. RECENT DEVELOPMENTS
14.15.5. DATABRIDGE ANALYSIS
14.16 FUKUDA SANGYO INC.
14.16.1. COMPANY OVERVIEW
14.16.2. FINANCIAL ANALYSIS
14.16.3. PRODUCT MATRIX
14.16.4. RECENT DEVELOPMENTS
14.16.5. DATABRIDGE ANALYSIS
14.17 CONTEC MEDICAL SYSTEMS CO., LTD.
14.17.1. COMPANY OVERVIEW
14.17.2. FINANCIAL ANALYSIS
14.17.3. PRODUCT MATRIX
14.17.4. RECENT DEVELOPMENTS
14.17.5. DATABRIDGE ANALYSIS
14.18 KONINKLIJKE PHILIPS N.V.
14.18.1. COMPANY OVERVIEW
14.18.2. FINANCIAL ANALYSIS
14.18.3. PRODUCT MATRIX
14.18.4. RECENT DEVELOPMENTS
14.18.5. DATABRIDGE ANALYSIS
14.19 BD
14.19.1. COMPANY OVERVIEW
14.19.2. FINANCIAL ANALYSIS
14.19.3. PRODUCT MATRIX
14.19.4. RECENT DEVELOPMENTS
14.19.5. DATABRIDGE ANALYSIS
14.20 CARDIOTECH
14.20.1. COMPANY OVERVIEW
14.20.2. FINANCIAL ANALYSIS
14.20.3. PRODUCT MATRIX
14.20.4. RECENT DEVELOPMENTS
14.20.5. DATABRIDGE ANALYSIS
15 APPENDIX
16 ABOUT DATA BRIDGE MARKET RESEARCH
